Dendritic cells, new tools for vaccination

Microbes and Infection

Volumn 5, Issue 4, 2003, Pages 311-319

  Colino, Jesus ^a   Snapper, Clifford M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Dendritic cells; Immunotherapy; Vaccines

Indexed keywords

ALPHA INTERFERON; ANTIGEN; BCG VACCINE; CHOLERA TOXIN; CHOLERA TOXIN A SUBUNIT; CYTOKINE; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN; INTERLEUKIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOSE RECEPTOR; MEMBRANE PROTEIN; OLIGODEOXYNUCLEOTIDE; OLIGONUCLEOTIDE; RECEPTOR PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTING CELL; CELL ACTIVATION; CELL FUNCTION; CELL VACUOLE; CELLULAR IMMUNITY; CPG ISLAND; CYTOLOGY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; HOST RESISTANCE; HUMAN; LEISHMANIASIS; LYMPHOCYTE HOMING; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; REVIEW; TARGET CELL; VACCINATION;

EID: 0037390013     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(03)00033-9     Document Type: Review

References (31)

1. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:2000;767-811.
2. Guermonprez P., Valladeau J., Zitvogel L., Thery C., Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:2002;621-667.
3. Neutra M.R., Mantis N.J., Frey A., Giannasca P.J. The composition and function of M cell apical membranes: implications for microbial pathogenesis. Semin. Immunol. 11:1999;171-181.
4. Winzler C., Rovere P., Rescigno M., Granucci F., Penna G., Adorini L., Zimmermann V.S., Davoust J., Ricciardi-Castagnoli P. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. M. 185:1997;317-328.
5. Turley S.J., Inaba K., Garrett W.S., Ebersold M., Unternaehrer J., Steinman R.M., Mellman I. Transport of peptide-MHC class II complexes in developing dendritic cells. Science. 288:2000;522-527.
6. Colino J., Shen Y., Snapper C.M. Dendritic cells pulsed with Intact Streptococcus pneumoniae elicit both protein- and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms. J. Exp. M. 195:2002;1-14.
7. Stoll S., Delon J., Brotz T.M., Germain R.N. Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science. 296:2002;1873-1876.
8. Lanzavecchia A., Sallusto F. Regulation of T cell immunity by dendritic cells. Cell. 106:2001;263-266.
9. Nestle F.O., Banchereau J., Hart D. Dendritic cells: on the move from bench to bedside. Nat. M. 7:2001;761-765.
10. Pulendran B., Smith J.L., Caspary G., Brasel K., Pettit D., Maraskovsky E., Maliszewski C.R. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA. 96:1999;1036-1041.
11. Gregory S.H., Sagnimeni A.J., Zurowski N.B., Thomson A.W. Flt3 ligand pretreatment promotes protective immunity to Listeria monocytogenes. Cytokine. 13:2001;202-208.
12. Kremer I.B., Gould M.P., Cooper K.D., Heinzel F.P. Pretreatment with recombinant Flt3 ligand partially protects against progressive cutaneous leishmaniasis in susceptible BALB/c mice. Infect. Immun. 69:2001;673-680.
13. Wortham C., Grinberg L., Kaslow D.C., Briles D.E., McDaniel L.S., Lees A., Flora M., Snapper C.M., Mond J.J. Enhanced protective antibody responses to PspA after intranasal or subcutaneous injections of PspA genetically fused to granulocyte-macrophage colony-stimulating factor or interleukin-2. Infect. Immun. 66:1998;1513-1520.
14. Wang J., Zganiacz A., Xing Z. Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation. Vaccine. 20:2002;2887-2898.
15. Williamson E., Westrich G.M., Viney J.L. Modulating dendritic cells to optimize mucosal immunization protocols. J. Immunol. 163:1999;3668-3675.
16. Le Bon A., Schiavoni G., D'Agostino G., Gresser I., Belardelli F., Tough D.F. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity. 14:2001;461-470.
17. Yamamoto S., Kiyono H., Yamamoto M., Imaoka K., Fujihashi K., Van Ginkel F.W., Noda M., Takeda Y., McGhee J.R. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. USA. 94:1997;5267-5272.
18. Merad M., Sugie T., Engleman E.G., Fong L. In vivo manipulation of dendritic cells to induce therapeutic immunity. Blood. 99:2002;1676-1682.
19. Demangel C., Britton W.J. Interaction of dendritic cells with mycobacteria: where the action starts. Immunol. Cell Biol. 78:2000;318-324.
20. Mbow M.L., Zeidner N., Panella N., Titus R.G., Piesman J. Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes. Infect. Immun. 65:1997;3386-3390.
21. Shaw J., Grund V., Durling L., Crane D., Caldwell H.D. Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective. Infect. Immun. 70:2002;1097-1105.
22. Bacci A., Montagnoli C., Perruccio K., Bozza S., Gaziano R., Pitzurra L., Velardi A., d'Ostiani C.F., Cutler J.E., Romani L. Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J. Immunol. 168:2002;2904-2913.
23. Lunde E., Western K.H., Rasmussen I.B., Sandlie I., Bogen B. Efficient delivery of T cell epitopes to APC by use of MHC class II-specific Troybodies. J. Immunol. 168:2002;2154-2162.
24. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J.V., Steinman R.M., Nussenzweig M.C. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. M. 194:2001;769-779.
25. Jarrossay D., Napolitani G., Colonna M., Sallusto F., Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31:2001;3388-3393.
26. Jeannin P., Renno T., Goetsch L., Miconnet I., Aubry J.P., Delneste Y., Herbault N., Baussant T., Magistrelli G., Soulas C., Romero P., Cerottini J.C., Bonnefoy J.Y. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. Nat. Immunol. 1:2000;502-509.
27. Srivastava P.K., Amato R.J. Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents. Vaccine. 19:2001;2590-2597.
28. Eggert A.A., Schreurs M.W., Boerman O.C., Oyen W.J., de Boer A.J., Punt C.J., Figdor C.G., Adema G.J. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res. 59:1999;3340-3345.
29. Balazs M., Martin F., Zhou T., Kearney J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity. 17:2002;341-352.
30. Wu M.T., Hwang S.T. CXCR5-transduced bone marrow-derived dendritic cells traffic to B-cell zones of lymph nodes and modify antigen-specific immune responses. J. Immunol. 168:2002;5096-5102.
31. Thery C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2:2002;569-579.